<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Zongyuan</First><Last>Yang</Last></Person>
    <Email>tjyzy2005@163.com</Email>
    <Phone>86-15827367673</Phone>
    <Department>Gyneconogical cancer</Department>
    <Organization>cancer biology center</Organization>
    <Address>
      <Line>Jiefang avenue 1095, Hankou,</Line>
      <City>Wuhan</City>
      <State>Hubei</State>
      <Postal-Code>430030</Postal-Code>
      <Country>China</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Organization></Organization>
    <Email>geo@ncbi.nlm.nih.gov, support@affymetrix.com</Email>
    <Phone>888-362-2447</Phone>
    <Organization>Affymetrix, Inc.</Organization>
    <Address>
      <City>Santa Clara</City>
      <State>CA</State>
      <Zip-Code>95051</Zip-Code>
      <Country>USA</Country>
    </Address>
    <Web-Link>http://www.affymetrix.com/index.affx</Web-Link>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Qinglei</First><Last>Gao</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL570">
    <Status database="GEO">
      <Submission-Date>2003-11-07</Submission-Date>
      <Release-Date>2003-11-07</Release-Date>
      <Last-Update-Date>2020-12-14</Last-Update-Date>
    </Status>
    <Title>[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array</Title>
    <Accession database="GEO">GPL570</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>commercial</Distribution>
    <Organism taxid="9606">Homo sapiens</Organism>
    <Manufacturer>Affymetrix</Manufacturer>
    <Manufacture-Protocol>
see manufacturer's web site

Complete coverage of the Human Genome U133 Set plus 6,500 additional genes for analysis of over 47,000 transcripts
All probe sets represented on the GeneChip Human Genome U133 Set are identically replicated on the GeneChip Human Genome U133 Plus 2.0 Array. The sequences from which these probe sets were derived were selected from GenBankÂ®, dbEST, and RefSeq. The sequence clusters were created from the UniGene database (Build 133, April 20, 2001) and then refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the University of California, Santa Cruz Golden-Path human genome database (April 2001 release).
In addition, there are 9,921 new probe sets representing approximately 6,500 new genes. These gene sequences were selected from GenBank, dbEST, and RefSeq. Sequence clusters were created from the UniGene database (Build 159, January 25, 2003) and refined by analysis and comparison with a number of other publicly available databases, including the Washington University EST trace repository and the NCBI human genome assembly (Build 31).

    </Manufacture-Protocol>
    <Description>
Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://www.ncbi.nlm.nih.gov/projects/geo/info/geo_affy.html

June 03, 2009: annotation table updated with netaffx build 28
June 06, 2012: annotation table updated with netaffx build 32
June 23, 2016: annotation table updated with netaffx build 35
    </Description>
    <Web-Link>http://www.affymetrix.com/support/technical/byproduct.affx?product=hg-u133-plus</Web-Link>
    <Web-Link>http://www.affymetrix.com/analysis/index.affx</Web-Link>
    <Relation type="Alternative to" target="GPL4454" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL4866" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL5760" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6671" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6791" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL6879" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL7567" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8019" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8542" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8715" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL8712" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9102" comment="Probe Level Version" />
    <Relation type="Alternative to" target="GPL9099" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9101" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9324" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9486" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL9987" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10175" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10335" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10371" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10526" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10881" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL10925" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11084" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11433" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL11670" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL13232" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 13.0.0]" />
    <Relation type="Alternative to" target="GPL13303" comment="Alternative CDF." />
    <Relation type="Alternative to" target="GPL13916" comment="[Brainarray ENSG Version 14.1]" />
    <Relation type="Alternative to" target="GPL14837" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL14877" comment="[Alternative CDF]" />
    <Relation type="Alternative to" target="GPL15394" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 14.0]" />
    <Relation type="Alternative to" target="GPL6732" comment="Alternative CDF [HGU133Plus2_Hs_REFSEQ, Brainarray version 7]" />
    <Relation type="Alternative to" target="GPL15445" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16066" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL16100" comment="Alternative CDF [GATExplorer_Ensembl v57]" />
    <Relation type="Alternative to" target="GPL16268" comment="Alternative CDF [Brainarray ENSG Version 16]" />
    <Relation type="Alternative to" target="GPL16273" comment="Alternative CDF [Brainarray ENSG Version 15]" />
    <Relation type="Alternative to" target="GPL16311" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG Brainarray version 14.0.0]" />
    <Relation type="Alternative to" target="GPL16356" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG 15.0.0]" />
    <Relation type="Alternative to" target="GPL16372" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_UG v.13]" />
    <Relation type="Alternative to" target="GPL17392" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 17.1]" />
    <Relation type="Alternative to" target="GPL17394" comment="Alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray 13.0]" />
    <Relation type="Alternative to" target="GPL17810" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 16]" />
    <Relation type="Alternative to" target="GPL17811" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 17]" />
    <Relation type="Alternative to" target="GPL17996" comment="Alternative CDF:HGU133Plus2_Hs_ENTREZG.cdf version 15.1.0" />
    <Relation type="Alternative to" target="GPL18121" comment="custom CDF" />
    <Relation type="Alternative to: GPL18756 (Alternative CDF [CDF" target="HGU133Plus2_Hs_ENTREZG_14.1.0])" />
    <Relation type="Alternative to" target="GPL18850" comment="Alternative CDF" />
    <Relation type="Alternative to" target="GPL18478" comment="Alternative CDF [Hs_ENTREZG_V13]" />
    <Relation type="Alternative to" target="GPL19109" comment="Alternative CDF [Brainarray HGU133Plus2_Hs_ENTREZG_v18]" />
    <Relation type="Alternative to" target="GPL19883" comment="Alternative CDF [Broad GenePattern]" />
    <Relation type="Alternative to" target="GPL19918" comment="Gene symbol version, 10K" />
    <Relation type="Alternative to" target="GPL20182" comment="Gene Symbol Version" />
    <Relation type="Alternative to" target="GPL22321" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 20]" />
    <Relation type="Alternative to" target="GPL22945" comment="alternative" />
    <Relation type="Alternative to" target="GPL23270" comment="(Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 21]" />
    <Relation type="Alternative to" target="GPL23432" comment="alternative CDF [HGU133Plus2_Hs_ENSG, Brainarray version 18.0.0]" />
    <Relation type="Alternative to" target="GPL25740" comment="alternative" />
    <Relation type="Alternative to" target="GPL28718" comment="Alternative CDF [HGU133Plus2_Hs_ENTREZG, Brainarray 23]" />
    <Relation type="Alternative to" target="GPL29499" comment="Alternative CDF" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
        <Description>Affymetrix Probe Set ID </Description>
        <Link-Prefix>https://www.affymetrix.com/LinkServlet?array=U133PLUS&amp;probeset=</Link-Prefix>
      </Column>
      <Column position="2">
        <Name>GB_ACC</Name>
        <Description>GenBank Accession Number </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/nuccore/?term=</Link-Prefix>
      </Column>
      <Column position="3">
        <Name>SPOT_ID</Name>
        <Description>identifies controls</Description>
      </Column>
      <Column position="4">
        <Name>Species Scientific Name</Name>
        <Description>The genus and species of the organism represented by the probe set.</Description>
      </Column>
      <Column position="5">
        <Name>Annotation Date</Name>
        <Description>The date that the annotations for this probe array were last updated. It will generally be earlier than the date when the annotations were posted on the Affymetrix web site.</Description>
      </Column>
      <Column position="6">
        <Name>Sequence Type</Name>
      </Column>
      <Column position="7">
        <Name>Sequence Source</Name>
        <Description>The database from which the sequence used to design this probe set was taken.</Description>
      </Column>
      <Column position="8">
        <Name>Target Description</Name>
      </Column>
      <Column position="9">
        <Name>Representative Public ID</Name>
        <Description>The accession number of a representative sequence. Note that for consensus-based probe sets, the representative sequence is only one of several sequences (sequence sub-clusters) used to build the consensus sequence and it is not directly used to derive the probe sequences. The representative sequence is chosen during array design as a sequence that is best associated with the transcribed region being interrogated by the probe set. Refer to the &quot;Sequence Source&quot; field to determine the database used.</Description>
      </Column>
      <Column position="10">
        <Name>Gene Title</Name>
        <Description>Title of Gene represented by the probe set.</Description>
      </Column>
      <Column position="11">
        <Name>Gene Symbol</Name>
        <Description>A gene symbol, when one is available (from UniGene).</Description>
      </Column>
      <Column position="12">
        <Name>ENTREZ_GENE_ID</Name>
        <Description>Entrez Gene Database UID  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/gene/</Link-Prefix>
        <Link-Delimiter> /// </Link-Delimiter>
      </Column>
      <Column position="13">
        <Name>RefSeq Transcript ID</Name>
        <Description>References to multiple sequences in RefSeq. The field contains the ID and Description for each entry, and there can be multiple entries per ProbeSet.</Description>
      </Column>
      <Column position="14">
        <Name>Gene Ontology Biological Process</Name>
        <Description>Gene Ontology Consortium Biological Process derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="15">
        <Name>Gene Ontology Cellular Component</Name>
        <Description>Gene Ontology Consortium Cellular Component derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
      <Column position="16">
        <Name>Gene Ontology Molecular Function</Name>
        <Description>Gene Ontology Consortium Molecular Function derived from LocusLink.  Each annotation consists of three parts: &quot;Accession Number // Description // Evidence&quot;. The description corresponds directly to the GO ID. The evidence can be &quot;direct&quot;, or &quot;extended&quot;.</Description>
      </Column>
    <Internal-Data rows="20">
1007_s_at	U48705		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	U48705 /FEATURE=mRNA /DEFINITION=HSU48705 Human receptor tyrosine kinase DDR gene, complete cds	U48705	discoidin domain receptor tyrosine kinase 1 /// microRNA 4640	DDR1 /// MIR4640	780 /// 100616237	NM_001202521 /// NM_001202522 /// NM_001202523 /// NM_001954 /// NM_013993 /// NM_013994 /// NR_039783 /// XM_005249385 /// XM_005249386 /// XM_005249387 /// XM_005249389 /// XM_005272873 /// XM_005272874 /// XM_005272875 /// XM_005272877 /// XM_005275027 /// XM_005275028 /// XM_005275030 /// XM_005275031 /// XM_005275162 /// XM_005275163 /// XM_005275164 /// XM_005275166 /// XM_005275457 /// XM_005275458 /// XM_005275459 /// XM_005275461 /// XM_006715185 /// XM_006715186 /// XM_006715187 /// XM_006715188 /// XM_006715189 /// XM_006715190 /// XM_006725501 /// XM_006725502 /// XM_006725503 /// XM_006725504 /// XM_006725505 /// XM_006725506 /// XM_006725714 /// XM_006725715 /// XM_006725716 /// XM_006725717 /// XM_006725718 /// XM_006725719 /// XM_006725720 /// XM_006725721 /// XM_006725722 /// XM_006725827 /// XM_006725828 /// XM_006725829 /// XM_006725830 /// XM_006725831 /// XM_006725832 /// XM_006726017 /// XM_006726018 /// XM_006726019 /// XM_006726020 /// XM_006726021 /// XM_006726022 /// XR_427836 /// XR_430858 /// XR_430938 /// XR_430974 /// XR_431015	0001558 // regulation of cell growth // inferred from electronic annotation /// 0001952 // regulation of cell-matrix adhesion // inferred from electronic annotation /// 0006468 // protein phosphorylation // inferred from electronic annotation /// 0007155 // cell adhesion // traceable author statement /// 0007169 // transmembrane receptor protein tyrosine kinase signaling pathway // inferred from electronic annotation /// 0007565 // female pregnancy // inferred from electronic annotation /// 0007566 // embryo implantation // inferred from electronic annotation /// 0007595 // lactation // inferred from electronic annotation /// 0008285 // negative regulation of cell proliferation // inferred from electronic annotation /// 0010715 // regulation of extracellular matrix disassembly // inferred from mutant phenotype /// 0014909 // smooth muscle cell migration // inferred from mutant phenotype /// 0016310 // phosphorylation // inferred from electronic annotation /// 0018108 // peptidyl-tyrosine phosphorylation // inferred from electronic annotation /// 0030198 // extracellular matrix organization // traceable author statement /// 0038063 // collagen-activated tyrosine kinase receptor signaling pathway // inferred from direct assay /// 0038063 // collagen-activated tyrosine kinase receptor signaling pathway // inferred from mutant phenotype /// 0038083 // peptidyl-tyrosine autophosphorylation // inferred from direct assay /// 0043583 // ear development // inferred from electronic annotation /// 0044319 // wound healing, spreading of cells // inferred from mutant phenotype /// 0046777 // protein autophosphorylation // inferred from direct assay /// 0060444 // branching involved in mammary gland duct morphogenesis // inferred from electronic annotation /// 0060749 // mammary gland alveolus development // inferred from electronic annotation /// 0061302 // smooth muscle cell-matrix adhesion // inferred from mutant phenotype	0005576 // extracellular region // inferred from electronic annotation /// 0005615 // extracellular space // inferred from direct assay /// 0005886 // plasma membrane // traceable author statement /// 0005887 // integral component of plasma membrane // traceable author statement /// 0016020 // membrane // inferred from electronic annotation /// 0016021 // integral component of membrane // inferred from electronic annotation /// 0043235 // receptor complex // inferred from direct assay /// 0070062 // extracellular vesicular exosome // inferred from direct assay	0000166 // nucleotide binding // inferred from electronic annotation /// 0004672 // protein kinase activity // inferred from electronic annotation /// 0004713 // protein tyrosine kinase activity // inferred from electronic annotation /// 0004714 // transmembrane receptor protein tyrosine kinase activity // traceable author statement /// 0005515 // protein binding // inferred from physical interaction /// 0005518 // collagen binding // inferred from direct assay /// 0005518 // collagen binding // inferred from mutant phenotype /// 0005524 // ATP binding // inferred from electronic annotation /// 0016301 // kinase activity // inferred from electronic annotation /// 0016740 // transferase activity // inferred from electronic annotation /// 0016772 // transferase activity, transferring phosphorus-containing groups // inferred from electronic annotation /// 0038062 // protein tyrosine kinase collagen receptor activity // inferred from direct assay /// 0046872 // metal ion binding // inferred from electronic annotation
1053_at	M87338		Homo sapiens	Oct 6, 2014	Exemplar sequence	GenBank	M87338 /FEATURE= /DEFINITION=HUMA1SBU Human replication factor C, 40-kDa subunit (A1) mRNA, complete cds	M87338	replication factor C (activator 1) 2, 40kDa	RFC2	5982	NM_001278791 /// NM_001278792 /// NM_001278793 /// NM_002914 /// NM_181471 /// XM_006716080	0000278 // mitotic cell cycle // traceable author statement /// 0000722 // telomere maintenance via recombination // traceable author statement /// 0000723 // telomere maintenance // traceable author statement /// 0006260 // DNA replication // traceable author statement /// 0006271 // DNA strand elongation involved in DNA replication // traceable author statement /// 0006281 // DNA repair // traceable author statement /// 0006283 // transcription-coupled nucleotide-excision repair // traceable author statement /// 0006289 // nucleotide-excision repair // traceable author statement /// 0006297 // nucleotide-excision repair, DNA gap filling // traceable author statement /// 0015979 // photosynthesis // inferred from electronic annotation /// 0015995 // chlorophyll biosynthetic process // inferred from electronic annotation /// 0032201 // telomere maintenance via semi-conservative replication // traceable author statement	0005634 // nucleus // inferred from electronic annotation /// 0005654 // nucleoplasm // traceable author statement /// 0005663 // DNA replication factor C complex // inferred from direct assay	0000166 // nucleotide binding // inferred from electronic annotation /// 0003677 // DNA binding // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0005524 // ATP binding // inferred from electronic annotation /// 0016851 // magnesium chelatase activity // inferred from electronic annotation /// 0017111 // nucleoside-triphosphatase activity // inferred from electronic annotation
117_at	X51757		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	X51757 /FEATURE=cds /DEFINITION=HSP70B Human heat-shock protein HSP70B' gene	X51757	heat shock 70kDa protein 6 (HSP70B')	HSPA6	3310	NM_002155	0000902 // cell morphogenesis // inferred from electronic annotation /// 0006200 // ATP catabolic process // inferred from direct assay /// 0006950 // response to stress // inferred from electronic annotation /// 0006986 // response to unfolded protein // traceable author statement /// 0034605 // cellular response to heat // inferred from direct assay /// 0042026 // protein refolding // inferred from direct assay /// 0070370 // cellular heat acclimation // inferred from mutant phenotype	0005737 // cytoplasm // inferred from direct assay /// 0005814 // centriole // inferred from direct assay /// 0005829 // cytosol // inferred from direct assay /// 0008180 // COP9 signalosome // inferred from direct assay /// 0070062 // extracellular vesicular exosome // inferred from direct assay /// 0072562 // blood microparticle // inferred from direct assay	0000166 // nucleotide binding // inferred from electronic annotation /// 0005524 // ATP binding // inferred from electronic annotation /// 0019899 // enzyme binding // inferred from physical interaction /// 0031072 // heat shock protein binding // inferred from physical interaction /// 0042623 // ATPase activity, coupled // inferred from direct assay /// 0051082 // unfolded protein binding // inferred from direct assay
121_at	X69699		Homo sapiens	Oct 6, 2014	Exemplar sequence	GenBank	X69699 /FEATURE= /DEFINITION=HSPAX8A H.sapiens Pax8 mRNA	X69699	paired box 8	PAX8	7849	NM_003466 /// NM_013951 /// NM_013952 /// NM_013953 /// NM_013992	0001655 // urogenital system development // inferred from sequence or structural similarity /// 0001656 // metanephros development // inferred from electronic annotation /// 0001658 // branching involved in ureteric bud morphogenesis // inferred from expression pattern /// 0001822 // kidney development // inferred from expression pattern /// 0001823 // mesonephros development // inferred from sequence or structural similarity /// 0003337 // mesenchymal to epithelial transition involved in metanephros morphogenesis // inferred from expression pattern /// 0006351 // transcription, DNA-templated // inferred from direct assay /// 0006355 // regulation of transcription, DNA-templated // inferred from electronic annotation /// 0007275 // multicellular organismal development // inferred from electronic annotation /// 0007417 // central nervous system development // inferred from expression pattern /// 0009653 // anatomical structure morphogenesis // traceable author statement /// 0030154 // cell differentiation // inferred from electronic annotation /// 0030878 // thyroid gland development // inferred from expression pattern /// 0030878 // thyroid gland development // inferred from mutant phenotype /// 0038194 // thyroid-stimulating hormone signaling pathway // traceable author statement /// 0039003 // pronephric field specification // inferred from sequence or structural similarity /// 0042472 // inner ear morphogenesis // inferred from sequence or structural similarity /// 0042981 // regulation of apoptotic process // inferred from sequence or structural similarity /// 0045893 // positive regulation of transcription, DNA-templated // inferred from direct assay /// 0045893 // positive regulation of transcription, DNA-templated // inferred from sequence or structural similarity /// 0045944 // positive regulation of transcription from RNA polymerase II promoter // inferred from direct assay /// 0048793 // pronephros development // inferred from sequence or structural similarity /// 0071371 // cellular response to gonadotropin stimulus // inferred from direct assay /// 0071599 // otic vesicle development // inferred from expression pattern /// 0072050 // S-shaped body morphogenesis // inferred from electronic annotation /// 0072073 // kidney epithelium development // inferred from electronic annotation /// 0072108 // positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis // inferred from sequence or structural similarity /// 0072164 // mesonephric tubule development // inferred from electronic annotation /// 0072207 // metanephric epithelium development // inferred from expression pattern /// 0072221 // metanephric distal convoluted tubule development // inferred from sequence or structural similarity /// 0072278 // metanephric comma-shaped body morphogenesis // inferred from expression pattern /// 0072284 // metanephric S-shaped body morphogenesis // inferred from expression pattern /// 0072289 // metanephric nephron tubule formation // inferred from sequence or structural similarity /// 0072305 // negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis // inferred from sequence or structural similarity /// 0072307 // regulation of metanephric nephron tubule epithelial cell differentiation // inferred from sequence or structural similarity /// 0090190 // positive regulation of branching involved in ureteric bud morphogenesis // inferred from sequence or structural similarity /// 1900212 // negative regulation of mesenchymal cell apoptotic process involved in metanephros development // inferred from sequence or structural similarity /// 1900215 // negative regulation of apoptotic process involved in metanephric collecting duct development // inferred from sequence or structural similarity /// 1900218 // negative regulation of apoptotic process involved in metanephric nephron tubule development // inferred from sequence or structural similarity /// 2000594 // positive regulation of metanephric DCT cell differentiation // inferred from sequence or structural similarity /// 2000611 // positive regulation of thyroid hormone generation // inferred from mutant phenotype /// 2000612 // regulation of thyroid-stimulating hormone secretion // inferred from mutant phenotype	0005634 // nucleus // inferred from direct assay /// 0005654 // nucleoplasm // inferred from sequence or structural similarity /// 0005730 // nucleolus // inferred from direct assay	0000979 // RNA polymerase II core promoter sequence-specific DNA binding // inferred from direct assay /// 0003677 // DNA binding // inferred from direct assay /// 0003677 // DNA binding // inferred from mutant phenotype /// 0003700 // sequence-specific DNA binding transcription factor activity // inferred from direct assay /// 0004996 // thyroid-stimulating hormone receptor activity // traceable author statement /// 0005515 // protein binding // inferred from physical interaction /// 0044212 // transcription regulatory region DNA binding // inferred from direct assay
1255_g_at	L36861		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	L36861 /FEATURE=expanded_cds /DEFINITION=HUMGCAPB Homo sapiens guanylate cyclase activating protein (GCAP) gene exons 1-4, complete cds	L36861	guanylate cyclase activator 1A (retina)	GUCA1A	2978	NM_000409 /// XM_006715073	0007165 // signal transduction // non-traceable author statement /// 0007601 // visual perception // inferred from electronic annotation /// 0007602 // phototransduction // inferred from electronic annotation /// 0007603 // phototransduction, visible light // traceable author statement /// 0016056 // rhodopsin mediated signaling pathway // traceable author statement /// 0022400 // regulation of rhodopsin mediated signaling pathway // traceable author statement /// 0030828 // positive regulation of cGMP biosynthetic process // inferred from electronic annotation /// 0031282 // regulation of guanylate cyclase activity // inferred from electronic annotation /// 0031284 // positive regulation of guanylate cyclase activity // inferred from electronic annotation /// 0050896 // response to stimulus // inferred from electronic annotation	0001750 // photoreceptor outer segment // inferred from electronic annotation /// 0001917 // photoreceptor inner segment // inferred from electronic annotation /// 0005578 // proteinaceous extracellular matrix // inferred from electronic annotation /// 0005886 // plasma membrane // inferred from direct assay /// 0016020 // membrane // inferred from electronic annotation /// 0097381 // photoreceptor disc membrane // traceable author statement	0005509 // calcium ion binding // inferred from electronic annotation /// 0008048 // calcium sensitive guanylate cyclase activator activity // inferred from electronic annotation /// 0030249 // guanylate cyclase regulator activity // inferred from electronic annotation /// 0046872 // metal ion binding // inferred from electronic annotation
1294_at	L13852		Homo sapiens	Oct 6, 2014	Exemplar sequence	GenBank	L13852 /FEATURE= /DEFINITION=HUME1URP Homo sapiens ubiquitin-activating enzyme E1 related protein mRNA, complete cds	L13852	microRNA 5193 /// ubiquitin-like modifier activating enzyme 7	MIR5193 /// UBA7	7318 /// 100847079	NM_003335 /// NR_049825 /// XM_005265430 /// XM_006713321	0006464 // cellular protein modification process // inferred from direct assay /// 0016567 // protein ubiquitination // not recorded /// 0016567 // protein ubiquitination // inferred from electronic annotation /// 0019221 // cytokine-mediated signaling pathway // traceable author statement /// 0019941 // modification-dependent protein catabolic process // not recorded /// 0032020 // ISG15-protein conjugation // inferred from direct assay /// 0032480 // negative regulation of type I interferon production // traceable author statement /// 0045087 // innate immune response // traceable author statement	0005634 // nucleus // not recorded /// 0005829 // cytosol // not recorded /// 0005829 // cytosol // traceable author statement	0000166 // nucleotide binding // inferred from electronic annotation /// 0003824 // catalytic activity // inferred from electronic annotation /// 0004839 // ubiquitin activating enzyme activity // not recorded /// 0004842 // ubiquitin-protein transferase activity // not recorded /// 0005524 // ATP binding // inferred from electronic annotation /// 0008641 // small protein activating enzyme activity // inferred from electronic annotation /// 0016874 // ligase activity // inferred from electronic annotation /// 0019782 // ISG15 activating enzyme activity // inferred from direct assay
1316_at	X55005		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	X55005 /FEATURE=mRNA /DEFINITION=HSCERBAR Homo sapiens mRNA for thyroid hormone receptor alpha 1 THRA1, (c-erbA-1 gene)	X55005	thyroid hormone receptor, alpha	THRA	7067	NM_001190918 /// NM_001190919 /// NM_003250 /// NM_199334	0000122 // negative regulation of transcription from RNA polymerase II promoter // inferred from direct assay /// 0000122 // negative regulation of transcription from RNA polymerase II promoter // inferred from mutant phenotype /// 0001502 // cartilage condensation // inferred from electronic annotation /// 0001503 // ossification // inferred from electronic annotation /// 0002155 // regulation of thyroid hormone mediated signaling pathway // inferred from electronic annotation /// 0005978 // glycogen biosynthetic process // inferred from sequence or structural similarity /// 0006351 // transcription, DNA-templated // inferred from electronic annotation /// 0006355 // regulation of transcription, DNA-templated // inferred from electronic annotation /// 0006357 // regulation of transcription from RNA polymerase II promoter // inferred from direct assay /// 0006366 // transcription from RNA polymerase II promoter // inferred from direct assay /// 0006367 // transcription initiation from RNA polymerase II promoter // traceable author statement /// 0007611 // learning or memory // inferred from electronic annotation /// 0007623 // circadian rhythm // inferred from electronic annotation /// 0008016 // regulation of heart contraction // inferred from electronic annotation /// 0008050 // female courtship behavior // inferred from electronic annotation /// 0009409 // response to cold // inferred from electronic annotation /// 0009755 // hormone-mediated signaling pathway // inferred from direct assay /// 0009887 // organ morphogenesis // inferred from electronic annotation /// 0010467 // gene expression // traceable author statement /// 0010498 // proteasomal protein catabolic process // inferred from sequence or structural similarity /// 0010831 // positive regulation of myotube differentiation // inferred from electronic annotation /// 0010871 // negative regulation of receptor biosynthetic process // inferred from mutant phenotype /// 0017055 // negative regulation of RNA polymerase II transcriptional preinitiation complex assembly // inferred from direct assay /// 0019216 // regulation of lipid metabolic process // inferred from sequence or structural similarity /// 0030154 // cell differentiation // inferred from electronic annotation /// 0030218 // erythrocyte differentiation // inferred from electronic annotation /// 0030522 // intracellular receptor signaling pathway // inferred from electronic annotation /// 0030878 // thyroid gland development // inferred from electronic annotation /// 0032922 // circadian regulation of gene expression // inferred from sequence or structural similarity /// 0033032 // regulation of myeloid cell apoptotic process // inferred from electronic annotation /// 0034144 // negative regulation of toll-like receptor 4 signaling pathway // inferred from mutant phenotype /// 0035947 // regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter // inferred from mutant phenotype /// 0042752 // regulation of circadian rhythm // inferred from sequence or structural similarity /// 0042994 // cytoplasmic sequestering of transcription factor // inferred from electronic annotation /// 0043401 // steroid hormone mediated signaling pathway // inferred from electronic annotation /// 0044321 // response to leptin // inferred from sequence or structural similarity /// 0045598 // regulation of fat cell differentiation // inferred from sequence or structural similarity /// 0045892 // negative regulation of transcription, DNA-templated // inferred from direct assay /// 0045893 // positive regulation of transcription, DNA-templated // inferred from sequence or structural similarity /// 0045925 // positive regulation of female receptivity // inferred from electronic annotation /// 0045944 // positive regulation of transcription from RNA polymerase II promoter // inferred from electronic annotation /// 0048511 // rhythmic process // inferred from electronic annotation /// 0050994 // regulation of lipid catabolic process // inferred from electronic annotation /// 0060086 // circadian temperature homeostasis // inferred from sequence or structural similarity /// 0060509 // Type I pneumocyte differentiation // inferred from electronic annotation /// 0061178 // regulation of insulin secretion involved in cellular response to glucose stimulus // inferred from sequence or structural similarity /// 0061469 // regulation of type B pancreatic cell proliferation // inferred from sequence or structural similarity /// 0070859 // positive regulation of bile acid biosynthetic process // inferred from sequence or structural similarity /// 0071222 // cellular response to lipopolysaccharide // inferred from mutant phenotype /// 2000143 // negative regulation of DNA-templated transcription, initiation // inferred from direct assay /// 2000188 // regulation of cholesterol homeostasis // inferred from sequence or structural similarity /// 2000189 // positive regulation of cholesterol homeostasis // inferred from direct assay	0000790 // nuclear chromatin // inferred from direct assay /// 0005634 // nucleus // inferred from direct assay /// 0005654 // nucleoplasm // traceable author statement /// 0005737 // cytoplasm // inferred from electronic annotation /// 0005737 // cytoplasm // inferred from sequence or structural similarity /// 0005829 // cytosol // inferred from direct assay /// 0030425 // dendrite // inferred from electronic annotation /// 0030425 // dendrite // inferred from sequence or structural similarity /// 0042995 // cell projection // inferred from electronic annotation /// 0043197 // dendritic spine // inferred from electronic annotation /// 0043197 // dendritic spine // inferred from sequence or structural similarity	0000978 // RNA polymerase II core promoter proximal region sequence-specific DNA binding // inferred from mutant phenotype /// 0001046 // core promoter sequence-specific DNA binding // inferred from direct assay /// 0001078 // RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription // inferred from direct assay /// 0001222 // transcription corepressor binding // inferred from direct assay /// 0001222 // transcription corepressor binding // inferred from mutant phenotype /// 0002153 // steroid receptor RNA activator RNA binding // inferred from electronic annotation /// 0003677 // DNA binding // inferred from electronic annotation /// 0003700 // sequence-specific DNA binding transcription factor activity // inferred from direct assay /// 0003707 // steroid hormone receptor activity // inferred from electronic annotation /// 0003714 // transcription corepressor activity // traceable author statement /// 0003727 // single-stranded RNA binding // inferred from electronic annotation /// 0004879 // ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity // traceable author statement /// 0004879 // ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity // inferred from electronic annotation /// 0004887 // thyroid hormone receptor activity // inferred from direct assay /// 0005515 // protein binding // inferred from physical interaction /// 0008134 // transcription factor binding // inferred from physical interaction /// 0008270 // zinc ion binding // inferred from electronic annotation /// 0017025 // TBP-class protein binding // inferred from direct assay /// 0019904 // protein domain specific binding // inferred from physical interaction /// 0020037 // heme binding // inferred from direct assay /// 0031490 // chromatin DNA binding // inferred from electronic annotation /// 0032403 // protein complex binding // inferred from electronic annotation /// 0043565 // sequence-specific DNA binding // inferred from electronic annotation /// 0044212 // transcription regulatory region DNA binding // inferred from direct assay /// 0046872 // metal ion binding // inferred from electronic annotation /// 0070324 // thyroid hormone binding // inferred from direct assay /// 0070324 // thyroid hormone binding // inferred from physical interaction
1320_at	X79510		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	X79510 /FEATURE=cds /DEFINITION=HSPTPD1 H.sapiens mRNA for protein-tyrosine-phosphatase D1	X79510	protein tyrosine phosphatase, non-receptor type 21	PTPN21	11099	NM_007039 /// XM_005267287 /// XM_006720011	0006470 // protein dephosphorylation // traceable author statement /// 0016311 // dephosphorylation // inferred from electronic annotation /// 0035335 // peptidyl-tyrosine dephosphorylation // inferred from electronic annotation /// 0035335 // peptidyl-tyrosine dephosphorylation // traceable author statement	0005737 // cytoplasm // inferred from electronic annotation /// 0005856 // cytoskeleton // inferred from electronic annotation	0004721 // phosphoprotein phosphatase activity // inferred from electronic annotation /// 0004725 // protein tyrosine phosphatase activity // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0016787 // hydrolase activity // inferred from electronic annotation /// 0016791 // phosphatase activity // inferred from electronic annotation
1405_i_at	M21121		Homo sapiens	Oct 6, 2014	Exemplar sequence	GenBank	M21121 /FEATURE= /DEFINITION=HUMTCSM Human T cell-specific protein (RANTES) mRNA, complete cds	M21121	chemokine (C-C motif) ligand 5	CCL5	6352	NM_001278736 /// NM_002985	0000165 // MAPK cascade // inferred from mutant phenotype /// 0002407 // dendritic cell chemotaxis // traceable author statement /// 0002548 // monocyte chemotaxis // inferred by curator /// 0002676 // regulation of chronic inflammatory response // traceable author statement /// 0006468 // protein phosphorylation // inferred from direct assay /// 0006816 // calcium ion transport // inferred from direct assay /// 0006874 // cellular calcium ion homeostasis // inferred from direct assay /// 0006887 // exocytosis // inferred from direct assay /// 0006935 // chemotaxis // non-traceable author statement /// 0006954 // inflammatory response // inferred from direct assay /// 0006955 // immune response // inferred from electronic annotation /// 0007159 // leukocyte cell-cell adhesion // inferred from direct assay /// 0007267 // cell-cell signaling // inferred from direct assay /// 0009615 // response to virus // traceable author statement /// 0009636 // response to toxic substance // inferred from direct assay /// 0010535 // positive regulation of activation of JAK2 kinase activity // traceable author statement /// 0010759 // positive regulation of macrophage chemotaxis // inferred from direct assay /// 0010820 // positive regulation of T cell chemotaxis // inferred from direct assay /// 0014068 // positive regulation of phosphatidylinositol 3-kinase signaling // inferred from direct assay /// 0014911 // positive regulation of smooth muscle cell migration // inferred from direct assay /// 0030335 // positive regulation of cell migration // inferred from direct assay /// 0031328 // positive regulation of cellular biosynthetic process // inferred from direct assay /// 0031584 // activation of phospholipase D activity // inferred from direct assay /// 0031663 // lipopolysaccharide-mediated signaling pathway // inferred from direct assay /// 0033634 // positive regulation of cell-cell adhesion mediated by integrin // inferred from direct assay /// 0034097 // response to cytokine // inferred from electronic annotation /// 0034112 // positive regulation of homotypic cell-cell adhesion // inferred from direct assay /// 0034612 // response to tumor necrosis factor // inferred from electronic annotation /// 0042102 // positive regulation of T cell proliferation // inferred from direct assay /// 0042119 // neutrophil activation // inferred from direct assay /// 0042327 // positive regulation of phosphorylation // inferred from direct assay /// 0042531 // positive regulation of tyrosine phosphorylation of STAT protein // inferred from direct assay /// 0043491 // protein kinase B signaling // inferred from mutant phenotype /// 0043623 // cellular protein complex assembly // inferred from direct assay /// 0043922 // negative regulation by host of viral transcription // inferred from direct assay /// 0044344 // cellular response to fibroblast growth factor stimulus // inferred from expression pattern /// 0045070 // positive regulation of viral genome replication // traceable author statement /// 0045071 // negative regulation of viral genome replication // inferred from direct assay /// 0045089 // positive regulation of innate immune response // traceable author statement /// 0045744 // negative regulation of G-protein coupled receptor protein signaling pathway // inferred from direct assay /// 0045785 // positive regulation of cell adhesion // inferred from direct assay /// 0045948 // positive regulation of translational initiation // non-traceable author statement /// 0046427 // positive regulation of JAK-STAT cascade // traceable author statement /// 0048245 // eosinophil chemotaxis // inferred from direct assay /// 0048246 // macrophage chemotaxis // traceable author statement /// 0048661 // positive regulation of smooth muscle cell proliferation // inferred from direct assay /// 0050679 // positive regulation of epithelial cell proliferation // inferred from electronic annotation /// 0050863 // regulation of T cell activation // inferred from direct assay /// 0050918 // positive chemotaxis // inferred from direct assay /// 0051262 // protein tetramerization // inferred from direct assay /// 0051928 // positive regulation of calcium ion transport // inferred from direct assay /// 0060326 // cell chemotaxis // inferred from electronic annotation /// 0061098 // positive regulation of protein tyrosine kinase activity // inferred from direct assay /// 0070098 // chemokine-mediated signaling pathway // traceable author statement /// 0070100 // negative regulation of chemokine-mediated signaling pathway // inferred from direct assay /// 0070233 // negative regulation of T cell apoptotic process // inferred from direct assay /// 0070234 // positive regulation of T cell apoptotic process // inferred from direct assay /// 0071346 // cellular response to interferon-gamma // inferred from expression pattern /// 0071347 // cellular response to interleukin-1 // inferred from expression pattern /// 0071356 // cellular response to tumor necrosis factor // inferred from expression pattern /// 0071407 // cellular response to organic cyclic compound // inferred from direct assay /// 0090026 // positive regulation of monocyte chemotaxis // inferred from direct assay /// 2000110 // negative regulation of macrophage apoptotic process // inferred from electronic annotation /// 2000406 // positive regulation of T cell migration // inferred from direct assay /// 2000503 // positive regulation of natural killer cell chemotaxis // inferred from direct assay	0005576 // extracellular region // traceable author statement /// 0005615 // extracellular space // inferred from electronic annotation /// 0005737 // cytoplasm // inferred from electronic annotation	0004435 // phosphatidylinositol phospholipase C activity // inferred from direct assay /// 0004672 // protein kinase activity // inferred from direct assay /// 0005125 // cytokine activity // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0008009 // chemokine activity // inferred from direct assay /// 0008009 // chemokine activity // non-traceable author statement /// 0016004 // phospholipase activator activity // inferred from direct assay /// 0030298 // receptor signaling protein tyrosine kinase activator activity // inferred from direct assay /// 0031726 // CCR1 chemokine receptor binding // inferred from direct assay /// 0031726 // CCR1 chemokine receptor binding // inferred from physical interaction /// 0031726 // CCR1 chemokine receptor binding // traceable author statement /// 0031729 // CCR4 chemokine receptor binding // traceable author statement /// 0031730 // CCR5 chemokine receptor binding // inferred from physical interaction /// 0042056 // chemoattractant activity // inferred from direct assay /// 0042379 // chemokine receptor binding // inferred from physical interaction /// 0042803 // protein homodimerization activity // inferred from direct assay /// 0043621 // protein self-association // inferred from direct assay /// 0046817 // chemokine receptor antagonist activity // inferred from direct assay
1431_at	J02843		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	J02843 /FEATURE=cds /DEFINITION=HUMCYPIIE Human cytochrome P450IIE1 (ethanol-inducible) gene, complete cds	J02843	cytochrome P450, family 2, subfamily E, polypeptide 1	CYP2E1	1571	NM_000773	0006641 // triglyceride metabolic process // inferred from electronic annotation /// 0006805 // xenobiotic metabolic process // traceable author statement /// 0008202 // steroid metabolic process // inferred from mutant phenotype /// 0010193 // response to ozone // inferred from electronic annotation /// 0010243 // response to organonitrogen compound // inferred from electronic annotation /// 0016098 // monoterpenoid metabolic process // inferred from direct assay /// 0017144 // drug metabolic process // inferred from direct assay /// 0017144 // drug metabolic process // inferred from mutant phenotype /// 0042493 // response to drug // inferred from electronic annotation /// 0044281 // small molecule metabolic process // traceable author statement /// 0045471 // response to ethanol // inferred from electronic annotation /// 0046483 // heterocycle metabolic process // inferred from direct assay /// 0055114 // oxidation-reduction process // inferred from direct assay	0000139 // Golgi membrane // inferred from electronic annotation /// 0005739 // mitochondrion // inferred from electronic annotation /// 0005783 // endoplasmic reticulum // inferred from electronic annotation /// 0005789 // endoplasmic reticulum membrane // traceable author statement /// 0016020 // membrane // inferred from electronic annotation /// 0031090 // organelle membrane // inferred from electronic annotation /// 0031227 // intrinsic component of endoplasmic reticulum membrane // inferred from electronic annotation /// 0043231 // intracellular membrane-bounded organelle // inferred from electronic annotation	0004497 // monooxygenase activity // inferred from direct assay /// 0005506 // iron ion binding // inferred from electronic annotation /// 0009055 // electron carrier activity // inferred from electronic annotation /// 0016491 // oxidoreductase activity // inferred from direct assay /// 0016705 // oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen // inferred from electronic annotation /// 0016709 // oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen // traceable author statement /// 0016712 // oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen // inferred from electronic annotation /// 0019825 // oxygen binding // traceable author statement /// 0019899 // enzyme binding // inferred from physical interaction /// 0020037 // heme binding // inferred from direct assay /// 0046872 // metal ion binding // inferred from electronic annotation /// 0070330 // aromatase activity // inferred from electronic annotation
1438_at	X75208		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	X75208 /FEATURE=cds /DEFINITION=HSPTKR H.sapiens HEK2 mRNA for protein tyrosine kinase receptor	X75208	EPH receptor B3	EPHB3	2049	NM_004443	0001525 // angiogenesis // inferred from sequence or structural similarity /// 0001655 // urogenital system development // inferred from sequence or structural similarity /// 0006468 // protein phosphorylation // inferred from electronic annotation /// 0007169 // transmembrane receptor protein tyrosine kinase signaling pathway // inferred from electronic annotation /// 0007275 // multicellular organismal development // inferred from electronic annotation /// 0007399 // nervous system development // inferred from electronic annotation /// 0007411 // axon guidance // inferred from sequence or structural similarity /// 0007413 // axonal fasciculation // inferred from sequence or structural similarity /// 0016310 // phosphorylation // inferred from electronic annotation /// 0016477 // cell migration // inferred from direct assay /// 0018108 // peptidyl-tyrosine phosphorylation // inferred from electronic annotation /// 0021952 // central nervous system projection neuron axonogenesis // inferred from electronic annotation /// 0022038 // corpus callosum development // inferred from sequence or structural similarity /// 0022407 // regulation of cell-cell adhesion // inferred from direct assay /// 0031290 // retinal ganglion cell axon guidance // inferred from electronic annotation /// 0032314 // regulation of Rac GTPase activity // inferred from direct assay /// 0034446 // substrate adhesion-dependent cell spreading // inferred from direct assay /// 0043088 // regulation of Cdc42 GTPase activity // inferred from direct assay /// 0046777 // protein autophosphorylation // inferred from direct assay /// 0048013 // ephrin receptor signaling pathway // inferred from direct assay /// 0048538 // thymus development // inferred from sequence or structural similarity /// 0048546 // digestive tract morphogenesis // inferred from sequence or structural similarity /// 0050770 // regulation of axonogenesis // inferred from sequence or structural similarity /// 0051965 // positive regulation of synapse assembly // inferred from sequence or structural similarity /// 0060021 // palate development // inferred from sequence or structural similarity /// 0060996 // dendritic spine development // inferred from sequence or structural similarity /// 0060997 // dendritic spine morphogenesis // inferred from sequence or structural similarity	0005886 // plasma membrane // inferred from electronic annotation /// 0005887 // integral component of plasma membrane // inferred from direct assay /// 0016020 // membrane // inferred from electronic annotation /// 0016021 // integral component of membrane // inferred from electronic annotation /// 0030425 // dendrite // inferred from electronic annotation /// 0042995 // cell projection // inferred from electronic annotation	0000166 // nucleotide binding // inferred from electronic annotation /// 0004672 // protein kinase activity // inferred from electronic annotation /// 0004713 // protein tyrosine kinase activity // inferred from electronic annotation /// 0004714 // transmembrane receptor protein tyrosine kinase activity // inferred from electronic annotation /// 0005003 // ephrin receptor activity // inferred from direct assay /// 0005515 // protein binding // inferred from electronic annotation /// 0005524 // ATP binding // inferred from electronic annotation /// 0008046 // axon guidance receptor activity // inferred from electronic annotation /// 0016301 // kinase activity // inferred from electronic annotation /// 0016740 // transferase activity // inferred from electronic annotation /// 0016772 // transferase activity, transferring phosphorus-containing groups // inferred from electronic annotation
1487_at	L38487		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	L38487 /FEATURE=mRNA /DEFINITION=HUMHERRA1 Human estrogen receptor-related protein (hERRa1) mRNA, 3' end, partial cds	L38487	estrogen-related receptor alpha	ESRRA	2101	NM_001282450 /// NM_001282451 /// NM_004451 /// XM_006718449 /// XM_006718450	0006351 // transcription, DNA-templated // inferred from electronic annotation /// 0006355 // regulation of transcription, DNA-templated // inferred from mutant phenotype /// 0006367 // transcription initiation from RNA polymerase II promoter // traceable author statement /// 0010467 // gene expression // traceable author statement /// 0030278 // regulation of ossification // inferred from electronic annotation /// 0030522 // intracellular receptor signaling pathway // traceable author statement /// 0042127 // regulation of cell proliferation // inferred from electronic annotation /// 0043401 // steroid hormone mediated signaling pathway // inferred from electronic annotation /// 0045667 // regulation of osteoblast differentiation // inferred from electronic annotation /// 0045670 // regulation of osteoclast differentiation // inferred from electronic annotation /// 0045893 // positive regulation of transcription, DNA-templated // inferred from electronic annotation /// 0045944 // positive regulation of transcription from RNA polymerase II promoter // inferred from sequence or structural similarity /// 0051216 // cartilage development // inferred from electronic annotation	0005634 // nucleus // inferred from direct assay /// 0005654 // nucleoplasm // traceable author statement /// 0005730 // nucleolus // inferred from direct assay /// 0015630 // microtubule cytoskeleton // inferred from direct assay /// 0045171 // intercellular bridge // inferred from direct assay	0003677 // DNA binding // traceable author statement /// 0003700 // sequence-specific DNA binding transcription factor activity // inferred from electronic annotation /// 0003707 // steroid hormone receptor activity // inferred from electronic annotation /// 0004879 // ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity // traceable author statement /// 0005496 // steroid binding // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0008270 // zinc ion binding // inferred from electronic annotation /// 0019904 // protein domain specific binding // inferred from physical interaction /// 0043565 // sequence-specific DNA binding // inferred from direct assay /// 0046872 // metal ion binding // inferred from electronic annotation
1494_f_at	M33318		Homo sapiens	Oct 6, 2014	Exemplar sequence	Affymetrix Proprietary Database	M33318 /FEATURE=mRNA /DEFINITION=HUMCPIIA3A Human cytochrome P450IIA3 (CYP2A3) mRNA, complete cds	M33318	cytochrome P450, family 2, subfamily A, polypeptide 6	CYP2A6	1548	NM_000762	0006805 // xenobiotic metabolic process // traceable author statement /// 0008202 // steroid metabolic process // inferred from mutant phenotype /// 0009804 // coumarin metabolic process // inferred from direct assay /// 0017144 // drug metabolic process // inferred from direct assay /// 0017144 // drug metabolic process // inferred from mutant phenotype /// 0042738 // exogenous drug catabolic process // inferred from direct assay /// 0044281 // small molecule metabolic process // traceable author statement /// 0046226 // coumarin catabolic process // inferred from direct assay /// 0055114 // oxidation-reduction process // inferred from electronic annotation	0005783 // endoplasmic reticulum // inferred from electronic annotation /// 0005789 // endoplasmic reticulum membrane // traceable author statement /// 0005881 // cytoplasmic microtubule // inferred from direct assay /// 0016020 // membrane // inferred from electronic annotation /// 0031090 // organelle membrane // inferred from electronic annotation /// 0043231 // intracellular membrane-bounded organelle // inferred from electronic annotation	0004497 // monooxygenase activity // inferred from electronic annotation /// 0005506 // iron ion binding // inferred from electronic annotation /// 0008389 // coumarin 7-hydroxylase activity // inferred from direct assay /// 0009055 // electron carrier activity // inferred from electronic annotation /// 0016491 // oxidoreductase activity // inferred from electronic annotation /// 0016705 // oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen // inferred from electronic annotation /// 0016712 // oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen // inferred from electronic annotation /// 0019825 // oxygen binding // traceable author statement /// 0019899 // enzyme binding // inferred from physical interaction /// 0020037 // heme binding // inferred from direct assay /// 0046872 // metal ion binding // inferred from electronic annotation /// 0070330 // aromatase activity // inferred from electronic annotation
1552256_a_at	NM_005505		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_005505.2 /DB_XREF=gi:21361199 /GEN=SCARB1 /TID=Hs2.180616.1 /CNT=302 /FEA=FLmRNA /TIER=FL+Stack /STK=102 /LL=949 /UG=Hs.180616 /DEF=Homo sapiens scavenger receptor class B, member 1 (SCARB1), mRNA. /PROD=scavenger receptor class B, member 1 /FL=gb:NM_005505.2	NM_005505	scavenger receptor class B, member 1	SCARB1	949	NM_001082959 /// NM_005505	0001935 // endothelial cell proliferation // inferred from electronic annotation /// 0006702 // androgen biosynthetic process // inferred from electronic annotation /// 0006707 // cholesterol catabolic process // inferred from electronic annotation /// 0006869 // lipid transport // inferred from electronic annotation /// 0006898 // receptor-mediated endocytosis // inferred from direct assay /// 0006910 // phagocytosis, recognition // inferred from electronic annotation /// 0007155 // cell adhesion // inferred from electronic annotation /// 0010595 // positive regulation of endothelial cell migration // traceable author statement /// 0010867 // positive regulation of triglyceride biosynthetic process // inferred from sequence or structural similarity /// 0010886 // positive regulation of cholesterol storage // inferred from direct assay /// 0010899 // regulation of phosphatidylcholine catabolic process // inferred from sequence or structural similarity /// 0015914 // phospholipid transport // inferred from sequence or structural similarity /// 0015920 // lipopolysaccharide transport // inferred from direct assay /// 0016032 // viral process // inferred from electronic annotation /// 0019048 // modulation by virus of host morphology or physiology // inferred from electronic annotation /// 0030301 // cholesterol transport // inferred from electronic annotation /// 0031663 // lipopolysaccharide-mediated signaling pathway // inferred from direct assay /// 0032497 // detection of lipopolysaccharide // inferred from direct assay /// 0033344 // cholesterol efflux // inferred from sequence or structural similarity /// 0034375 // high-density lipoprotein particle remodeling // inferred from sequence or structural similarity /// 0034383 // low-density lipoprotein particle clearance // inferred from sequence or structural similarity /// 0034384 // high-density lipoprotein particle clearance // inferred from direct assay /// 0042060 // wound healing // traceable author statement /// 0042157 // lipoprotein metabolic process // traceable author statement /// 0042632 // cholesterol homeostasis // inferred from sequence or structural similarity /// 0043534 // blood vessel endothelial cell migration // inferred from electronic annotation /// 0043654 // recognition of apoptotic cell // inferred from direct assay /// 0043691 // reverse cholesterol transport // inferred from expression pattern /// 0044281 // small molecule metabolic process // traceable author statement /// 0044406 // adhesion of symbiont to host // inferred from mutant phenotype /// 0050764 // regulation of phagocytosis // inferred by curator /// 0051000 // positive regulation of nitric-oxide synthase activity // inferred from direct assay /// 0070328 // triglyceride homeostasis // inferred from sequence or structural similarity /// 0070508 // cholesterol import // inferred from sequence or structural similarity	0005737 // cytoplasm // inferred from electronic annotation /// 0005765 // lysosomal membrane // inferred from direct assay /// 0005886 // plasma membrane // inferred from direct assay /// 0005886 // plasma membrane // traceable author statement /// 0005887 // integral component of plasma membrane // inferred from electronic annotation /// 0005901 // caveola // traceable author statement /// 0009986 // cell surface // inferred from electronic annotation /// 0016020 // membrane // inferred from electronic annotation /// 0016021 // integral component of membrane // inferred from electronic annotation /// 0030666 // endocytic vesicle membrane // traceable author statement /// 0031528 // microvillus membrane // inferred from electronic annotation /// 0070062 // extracellular vesicular exosome // inferred from direct assay	0001530 // lipopolysaccharide binding // inferred from direct assay /// 0001786 // phosphatidylserine binding // inferred from sequence or structural similarity /// 0001875 // lipopolysaccharide receptor activity // inferred from direct assay /// 0005215 // transporter activity // traceable author statement /// 0005515 // protein binding // inferred from physical interaction /// 0005545 // 1-phosphatidylinositol binding // traceable author statement /// 0008035 // high-density lipoprotein particle binding // inferred from electronic annotation /// 0030169 // low-density lipoprotein particle binding // inferred from direct assay /// 0034185 // apolipoprotein binding // inferred from physical interaction /// 0034186 // apolipoprotein A-I binding // inferred from physical interaction /// 0042803 // protein homodimerization activity // inferred from electronic annotation /// 0070506 // high-density lipoprotein particle receptor activity // inferred from direct assay
1552257_a_at	NM_015140		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_015140.1 /DB_XREF=gi:11056035 /TID=Hs2.82563.1 /CNT=210 /FEA=FLmRNA /TIER=FL+Stack /STK=57 /LL=23170 /UG_GENE=KIAA0153 /UG=Hs.82563 /UG_TITLE=KIAA0153 protein /DEF=Homo sapiens KIAA0153 protein (KIAA0153), mRNA. /FL=gb:NM_015140.1 gb:BC001070.1	NM_015140	tubulin tyrosine ligase-like family, member 12	TTLL12	23170	NM_015140	0006464 // cellular protein modification process // inferred from electronic annotation		
1552258_at	NM_052871		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_052871.1 /DB_XREF=gi:16418372 /TID=Hs2.432419.1 /CNT=37 /FEA=FLmRNA /TIER=FL+Stack /STK=25 /LL=112597 /UG_GENE=MGC4677 /UG=Hs.432419 /UG_TITLE=hypothetical protein MGC4677 /DEF=Homo sapiens hypothetical protein MGC4677 (MGC4677), mRNA. /FL=gb:BC010491.1 gb:NM_052871.1	NM_052871	long intergenic non-protein coding RNA 152 /// uncharacterized LOC101930489	LINC00152 /// LOC101930489	112597 /// 101930489	NM_052871 /// NR_024204 /// NR_024205 /// NR_024206 /// XR_249188 /// XR_425456 /// XR_425457 /// XR_425458			
1552261_at	NM_080735		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_080735.1 /DB_XREF=gi:18379359 /GEN=WFDC2 /TID=Hs2.2719.2 /CNT=26 /FEA=FLmRNA /TIER=FL+Stack /STK=23 /LL=10406 /UG=Hs.2719 /DEF=Homo sapiens WAP four-disulfide core domain 2 (WFDC2), transcript variant 5, mRNA. /PROD=WAP four-disulfide core domain 2, isoform 5 /FL=gb:NM_080735.1 gb:AF330261.1	NM_080735	WAP four-disulfide core domain 2	WFDC2	10406	NM_006103 /// NM_080733 /// NM_080734 /// NM_080735 /// NM_080736	0006508 // proteolysis // traceable author statement /// 0007283 // spermatogenesis // traceable author statement /// 0010466 // negative regulation of peptidase activity // inferred from electronic annotation /// 0010951 // negative regulation of endopeptidase activity // inferred from electronic annotation /// 0010951 // negative regulation of endopeptidase activity // traceable author statement	0005576 // extracellular region // inferred from electronic annotation /// 0005615 // extracellular space // traceable author statement /// 0070062 // extracellular vesicular exosome // inferred from direct assay	0004866 // endopeptidase inhibitor activity // traceable author statement /// 0004867 // serine-type endopeptidase inhibitor activity // inferred from electronic annotation /// 0004869 // cysteine-type endopeptidase inhibitor activity // inferred from electronic annotation /// 0019828 // aspartic-type endopeptidase inhibitor activity // inferred from electronic annotation /// 0030414 // peptidase inhibitor activity // inferred from electronic annotation
1552263_at	NM_138957		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_138957.1 /DB_XREF=gi:20986530 /GEN=MAPK1 /TID=Hs2.324473.2 /CNT=74 /FEA=FLmRNA /TIER=FL+Stack /STK=16 /LL=5594 /UG=Hs.324473 /DEF=Homo sapiens mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, mRNA. /PROD=mitogen-activated protein kinase 1 /FL=gb:NM_138957.1 gb:BC017832.1	NM_138957	mitogen-activated protein kinase 1	MAPK1	5594	NM_002745 /// NM_138957	0000165 // MAPK cascade // traceable author statement /// 0000186 // activation of MAPKK activity // traceable author statement /// 0000187 // activation of MAPK activity // traceable author statement /// 0000189 // MAPK import into nucleus // inferred from electronic annotation /// 0002224 // toll-like receptor signaling pathway // traceable author statement /// 0002755 // MyD88-dependent toll-like receptor signaling pathway // traceable author statement /// 0002756 // MyD88-independent toll-like receptor signaling pathway // traceable author statement /// 0006351 // transcription, DNA-templated // inferred from electronic annotation /// 0006355 // regulation of transcription, DNA-templated // inferred from electronic annotation /// 0006468 // protein phosphorylation // inferred from electronic annotation /// 0006915 // apoptotic process // inferred from electronic annotation /// 0006935 // chemotaxis // traceable author statement /// 0006950 // response to stress // traceable author statement /// 0006974 // cellular response to DNA damage stimulus // inferred from electronic annotation /// 0007049 // cell cycle // inferred from electronic annotation /// 0007165 // signal transduction // traceable author statement /// 0007173 // epidermal growth factor receptor signaling pathway // traceable author statement /// 0007264 // small GTPase mediated signal transduction // traceable author statement /// 0007265 // Ras protein signal transduction // traceable author statement /// 0007268 // synaptic transmission // traceable author statement /// 0007411 // axon guidance // traceable author statement /// 0007596 // blood coagulation // traceable author statement /// 0008284 // positive regulation of cell proliferation // inferred from electronic annotation /// 0008286 // insulin receptor signaling pathway // traceable author statement /// 0008543 // fibroblast growth factor receptor signaling pathway // traceable author statement /// 0009636 // response to toxic substance // inferred from electronic annotation /// 0009887 // organ morphogenesis // inferred from electronic annotation /// 0010800 // positive regulation of peptidyl-threonine phosphorylation // inferred from direct assay /// 0016032 // viral process // inferred from electronic annotation /// 0016310 // phosphorylation // inferred from electronic annotation /// 0018105 // peptidyl-serine phosphorylation // inferred from direct assay /// 0018107 // peptidyl-threonine phosphorylation // inferred from sequence or structural similarity /// 0019048 // modulation by virus of host morphology or physiology // inferred from electronic annotation /// 0019233 // sensory perception of pain // inferred from electronic annotation /// 0019858 // cytosine metabolic process // inferred from electronic annotation /// 0030168 // platelet activation // traceable author statement /// 0030335 // positive regulation of cell migration // inferred from electronic annotation /// 0031647 // regulation of protein stability // inferred from sequence or structural similarity /// 0031663 // lipopolysaccharide-mediated signaling pathway // inferred from electronic annotation /// 0032496 // response to lipopolysaccharide // inferred from electronic annotation /// 0032872 // regulation of stress-activated MAPK cascade // traceable author statement /// 0033598 // mammary gland epithelial cell proliferation // inferred from electronic annotation /// 0034134 // toll-like receptor 2 signaling pathway // traceable author statement /// 0034138 // toll-like receptor 3 signaling pathway // traceable author statement /// 0034142 // toll-like receptor 4 signaling pathway // traceable author statement /// 0034146 // toll-like receptor 5 signaling pathway // traceable author statement /// 0034162 // toll-like receptor 9 signaling pathway // traceable author statement /// 0034166 // toll-like receptor 10 signaling pathway // traceable author statement /// 0035556 // intracellular signal transduction // inferred from electronic annotation /// 0035666 // TRIF-dependent toll-like receptor signaling pathway // traceable author statement /// 0038095 // Fc-epsilon receptor signaling pathway // traceable author statement /// 0038096 // Fc-gamma receptor signaling pathway involved in phagocytosis // traceable author statement /// 0038123 // toll-like receptor TLR1:TLR2 signaling pathway // traceable author statement /// 0038124 // toll-like receptor TLR6:TLR2 signaling pathway // traceable author statement /// 0038127 // ERBB signaling pathway // inferred from direct assay /// 0042221 // response to chemical // inferred from electronic annotation /// 0043330 // response to exogenous dsRNA // inferred from electronic annotation /// 0043627 // response to estrogen // inferred from electronic annotation /// 0045087 // innate immune response // traceable author statement /// 0045596 // negative regulation of cell differentiation // inferred from electronic annotation /// 0045727 // positive regulation of translation // inferred from electronic annotation /// 0045893 // positive regulation of transcription, DNA-templated // inferred from electronic annotation /// 0048011 // neurotrophin TRK receptor signaling pathway // traceable author statement /// 0050852 // T cell receptor signaling pathway // inferred from electronic annotation /// 0050853 // B cell receptor signaling pathway // inferred from electronic annotation /// 0051090 // regulation of sequence-specific DNA binding transcription factor activity // traceable author statement /// 0051403 // stress-activated MAPK cascade // traceable author statement /// 0051493 // regulation of cytoskeleton organization // traceable author statement /// 0060397 // JAK-STAT cascade involved in growth hormone signaling pathway // traceable author statement /// 0060716 // labyrinthine layer blood vessel development // inferred from electronic annotation /// 0070371 // ERK1 and ERK2 cascade // inferred from direct assay /// 0070371 // ERK1 and ERK2 cascade // traceable author statement /// 0070849 // response to epidermal growth factor // inferred from direct assay /// 0072584 // caveolin-mediated endocytosis // traceable author statement /// 0090170 // regulation of Golgi inheritance // traceable author statement /// 2000641 // regulation of early endosome to late endosome transport // traceable author statement	0005634 // nucleus // inferred from direct assay /// 0005634 // nucleus // traceable author statement /// 0005654 // nucleoplasm // traceable author statement /// 0005730 // nucleolus // inferred from direct assay /// 0005737 // cytoplasm // inferred from direct assay /// 0005737 // cytoplasm // inferred from sequence or structural similarity /// 0005739 // mitochondrion // traceable author statement /// 0005769 // early endosome // traceable author statement /// 0005770 // late endosome // traceable author statement /// 0005794 // Golgi apparatus // traceable author statement /// 0005815 // microtubule organizing center // inferred from electronic annotation /// 0005819 // spindle // inferred from electronic annotation /// 0005829 // cytosol // traceable author statement /// 0005856 // cytoskeleton // traceable author statement /// 0005901 // caveola // traceable author statement /// 0005925 // focal adhesion // traceable author statement /// 0015630 // microtubule cytoskeleton // inferred from direct assay /// 0031143 // pseudopodium // inferred from electronic annotation /// 0032839 // dendrite cytoplasm // inferred from electronic annotation /// 0043204 // perikaryon // inferred from electronic annotation /// 0043234 // protein complex // inferred from electronic annotation /// 0070062 // extracellular vesicular exosome // inferred from direct assay /// 0072686 // mitotic spindle // inferred from sequence or structural similarity	0000166 // nucleotide binding // inferred from electronic annotation /// 0001784 // phosphotyrosine binding // inferred from electronic annotation /// 0003677 // DNA binding // inferred from electronic annotation /// 0004672 // protein kinase activity // inferred from electronic annotation /// 0004674 // protein serine/threonine kinase activity // inferred from direct assay /// 0004707 // MAP kinase activity // inferred from electronic annotation /// 0004713 // protein tyrosine kinase activity // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0005524 // ATP binding // inferred from electronic annotation /// 0008134 // transcription factor binding // inferred from electronic annotation /// 0008353 // RNA polymerase II carboxy-terminal domain kinase activity // inferred from sequence or structural similarity /// 0016301 // kinase activity // inferred from electronic annotation /// 0016740 // transferase activity // inferred from electronic annotation /// 0016772 // transferase activity, transferring phosphorus-containing groups // inferred from electronic annotation /// 0019902 // phosphatase binding // inferred from physical interaction /// 0031435 // mitogen-activated protein kinase kinase kinase binding // inferred from electronic annotation
1552264_a_at	NM_138957		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_138957.1 /DB_XREF=gi:20986530 /GEN=MAPK1 /TID=Hs2.324473.2 /CNT=74 /FEA=FLmRNA /TIER=FL+Stack /STK=16 /LL=5594 /UG=Hs.324473 /DEF=Homo sapiens mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, mRNA. /PROD=mitogen-activated protein kinase 1 /FL=gb:NM_138957.1 gb:BC017832.1	NM_138957	mitogen-activated protein kinase 1	MAPK1	5594	NM_002745 /// NM_138957	0000165 // MAPK cascade // traceable author statement /// 0000186 // activation of MAPKK activity // traceable author statement /// 0000187 // activation of MAPK activity // traceable author statement /// 0000189 // MAPK import into nucleus // inferred from electronic annotation /// 0002224 // toll-like receptor signaling pathway // traceable author statement /// 0002755 // MyD88-dependent toll-like receptor signaling pathway // traceable author statement /// 0002756 // MyD88-independent toll-like receptor signaling pathway // traceable author statement /// 0006351 // transcription, DNA-templated // inferred from electronic annotation /// 0006355 // regulation of transcription, DNA-templated // inferred from electronic annotation /// 0006468 // protein phosphorylation // inferred from electronic annotation /// 0006915 // apoptotic process // inferred from electronic annotation /// 0006935 // chemotaxis // traceable author statement /// 0006950 // response to stress // traceable author statement /// 0006974 // cellular response to DNA damage stimulus // inferred from electronic annotation /// 0007049 // cell cycle // inferred from electronic annotation /// 0007165 // signal transduction // traceable author statement /// 0007173 // epidermal growth factor receptor signaling pathway // traceable author statement /// 0007264 // small GTPase mediated signal transduction // traceable author statement /// 0007265 // Ras protein signal transduction // traceable author statement /// 0007268 // synaptic transmission // traceable author statement /// 0007411 // axon guidance // traceable author statement /// 0007596 // blood coagulation // traceable author statement /// 0008284 // positive regulation of cell proliferation // inferred from electronic annotation /// 0008286 // insulin receptor signaling pathway // traceable author statement /// 0008543 // fibroblast growth factor receptor signaling pathway // traceable author statement /// 0009636 // response to toxic substance // inferred from electronic annotation /// 0009887 // organ morphogenesis // inferred from electronic annotation /// 0010800 // positive regulation of peptidyl-threonine phosphorylation // inferred from direct assay /// 0016032 // viral process // inferred from electronic annotation /// 0016310 // phosphorylation // inferred from electronic annotation /// 0018105 // peptidyl-serine phosphorylation // inferred from direct assay /// 0018107 // peptidyl-threonine phosphorylation // inferred from sequence or structural similarity /// 0019048 // modulation by virus of host morphology or physiology // inferred from electronic annotation /// 0019233 // sensory perception of pain // inferred from electronic annotation /// 0019858 // cytosine metabolic process // inferred from electronic annotation /// 0030168 // platelet activation // traceable author statement /// 0030335 // positive regulation of cell migration // inferred from electronic annotation /// 0031647 // regulation of protein stability // inferred from sequence or structural similarity /// 0031663 // lipopolysaccharide-mediated signaling pathway // inferred from electronic annotation /// 0032496 // response to lipopolysaccharide // inferred from electronic annotation /// 0032872 // regulation of stress-activated MAPK cascade // traceable author statement /// 0033598 // mammary gland epithelial cell proliferation // inferred from electronic annotation /// 0034134 // toll-like receptor 2 signaling pathway // traceable author statement /// 0034138 // toll-like receptor 3 signaling pathway // traceable author statement /// 0034142 // toll-like receptor 4 signaling pathway // traceable author statement /// 0034146 // toll-like receptor 5 signaling pathway // traceable author statement /// 0034162 // toll-like receptor 9 signaling pathway // traceable author statement /// 0034166 // toll-like receptor 10 signaling pathway // traceable author statement /// 0035556 // intracellular signal transduction // inferred from electronic annotation /// 0035666 // TRIF-dependent toll-like receptor signaling pathway // traceable author statement /// 0038095 // Fc-epsilon receptor signaling pathway // traceable author statement /// 0038096 // Fc-gamma receptor signaling pathway involved in phagocytosis // traceable author statement /// 0038123 // toll-like receptor TLR1:TLR2 signaling pathway // traceable author statement /// 0038124 // toll-like receptor TLR6:TLR2 signaling pathway // traceable author statement /// 0038127 // ERBB signaling pathway // inferred from direct assay /// 0042221 // response to chemical // inferred from electronic annotation /// 0043330 // response to exogenous dsRNA // inferred from electronic annotation /// 0043627 // response to estrogen // inferred from electronic annotation /// 0045087 // innate immune response // traceable author statement /// 0045596 // negative regulation of cell differentiation // inferred from electronic annotation /// 0045727 // positive regulation of translation // inferred from electronic annotation /// 0045893 // positive regulation of transcription, DNA-templated // inferred from electronic annotation /// 0048011 // neurotrophin TRK receptor signaling pathway // traceable author statement /// 0050852 // T cell receptor signaling pathway // inferred from electronic annotation /// 0050853 // B cell receptor signaling pathway // inferred from electronic annotation /// 0051090 // regulation of sequence-specific DNA binding transcription factor activity // traceable author statement /// 0051403 // stress-activated MAPK cascade // traceable author statement /// 0051493 // regulation of cytoskeleton organization // traceable author statement /// 0060397 // JAK-STAT cascade involved in growth hormone signaling pathway // traceable author statement /// 0060716 // labyrinthine layer blood vessel development // inferred from electronic annotation /// 0070371 // ERK1 and ERK2 cascade // inferred from direct assay /// 0070371 // ERK1 and ERK2 cascade // traceable author statement /// 0070849 // response to epidermal growth factor // inferred from direct assay /// 0072584 // caveolin-mediated endocytosis // traceable author statement /// 0090170 // regulation of Golgi inheritance // traceable author statement /// 2000641 // regulation of early endosome to late endosome transport // traceable author statement	0005634 // nucleus // inferred from direct assay /// 0005634 // nucleus // traceable author statement /// 0005654 // nucleoplasm // traceable author statement /// 0005730 // nucleolus // inferred from direct assay /// 0005737 // cytoplasm // inferred from direct assay /// 0005737 // cytoplasm // inferred from sequence or structural similarity /// 0005739 // mitochondrion // traceable author statement /// 0005769 // early endosome // traceable author statement /// 0005770 // late endosome // traceable author statement /// 0005794 // Golgi apparatus // traceable author statement /// 0005815 // microtubule organizing center // inferred from electronic annotation /// 0005819 // spindle // inferred from electronic annotation /// 0005829 // cytosol // traceable author statement /// 0005856 // cytoskeleton // traceable author statement /// 0005901 // caveola // traceable author statement /// 0005925 // focal adhesion // traceable author statement /// 0015630 // microtubule cytoskeleton // inferred from direct assay /// 0031143 // pseudopodium // inferred from electronic annotation /// 0032839 // dendrite cytoplasm // inferred from electronic annotation /// 0043204 // perikaryon // inferred from electronic annotation /// 0043234 // protein complex // inferred from electronic annotation /// 0070062 // extracellular vesicular exosome // inferred from direct assay /// 0072686 // mitotic spindle // inferred from sequence or structural similarity	0000166 // nucleotide binding // inferred from electronic annotation /// 0001784 // phosphotyrosine binding // inferred from electronic annotation /// 0003677 // DNA binding // inferred from electronic annotation /// 0004672 // protein kinase activity // inferred from electronic annotation /// 0004674 // protein serine/threonine kinase activity // inferred from direct assay /// 0004707 // MAP kinase activity // inferred from electronic annotation /// 0004713 // protein tyrosine kinase activity // inferred from electronic annotation /// 0005515 // protein binding // inferred from physical interaction /// 0005524 // ATP binding // inferred from electronic annotation /// 0008134 // transcription factor binding // inferred from electronic annotation /// 0008353 // RNA polymerase II carboxy-terminal domain kinase activity // inferred from sequence or structural similarity /// 0016301 // kinase activity // inferred from electronic annotation /// 0016740 // transferase activity // inferred from electronic annotation /// 0016772 // transferase activity, transferring phosphorus-containing groups // inferred from electronic annotation /// 0019902 // phosphatase binding // inferred from physical interaction /// 0031435 // mitogen-activated protein kinase kinase kinase binding // inferred from electronic annotation
1552266_at	NM_145004		Homo sapiens	Oct 6, 2014	Consensus sequence	GenBank	gb:NM_145004.1 /DB_XREF=gi:21450712 /TID=Hs2.338203.1 /CNT=38 /FEA=FLmRNA /TIER=FL+Stack /STK=15 /LL=203102 /UG_GENE=MGC26899 /UG=Hs.338203 /UG_TITLE=hypothetical protein MGC26899 /DEF=Homo sapiens a disintegrin and metalloprotease domain 32 (ADAM32), mRNA. /FL=gb:BC030698.1 gb:NM_145004.1 gb:BC030014.1 gb:BC026085.1 gb:BC028702.1 gb:BC026169.1 gb:BC034975.1	NM_145004	ADAM metallopeptidase domain 32	ADAM32	203102	NM_145004 /// XM_006716298 /// XM_006716299 /// XM_006725117 /// XM_006725118 /// XR_430696	0006508 // proteolysis // inferred from electronic annotation /// 0007229 // integrin-mediated signaling pathway // inferred from electronic annotation	0016020 // membrane // inferred from electronic annotation /// 0016021 // integral component of membrane // inferred from electronic annotation	0004222 // metalloendopeptidase activity // inferred from electronic annotation /// 0005515 // protein binding // inferred from electronic annotation /// 0008233 // peptidase activity // inferred from electronic annotation /// 0008237 // metallopeptidase activity // inferred from electronic annotation /// 0008270 // zinc ion binding // inferred from electronic annotation
    </Internal-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM1885279">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient1 primary tumor cells</Title>
    <Accession database="GEO">GSM1885279</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient primary tumor</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
primary
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from primary tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885279/suppl/GSM1885279_LGSOC-Patient01_primary_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	2200.964	P
1053_at	221.1945	P
117_at	44.24419	A
121_at	617.3943	P
1255_g_at	41.6278	A
1294_at	362.6707	P
1316_at	242.5731	P
1320_at	88.42698	A
1405_i_at	124.5676	P
1431_at	92.14423	P
1438_at	32.28019	A
1487_at	481.5038	P
1494_f_at	94.68842	A
1552256_a_at	931.7369	P
1552257_a_at	1999.683	P
1552258_at	104.8575	P
1552261_at	35.51213	A
1552263_at	409.8742	P
1552264_a_at	341.7808	P
1552266_at	13.39048	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885280">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient1 ascites tumor cells</Title>
    <Accession database="GEO">GSM1885280</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient ascites</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
ascitic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from ascitic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885280/suppl/GSM1885280_LGSOC-Patient01_ascites_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	5255.096	P
1053_at	132.7435	P
117_at	25.69468	A
121_at	1055.344	P
1255_g_at	19.76038	A
1294_at	682.3401	P
1316_at	307.3056	P
1320_at	62.25737	A
1405_i_at	63.72689	P
1431_at	96.75267	P
1438_at	40.62233	A
1487_at	491.757	P
1494_f_at	38.42388	A
1552256_a_at	1452.488	P
1552257_a_at	1165.39	P
1552258_at	120.7795	A
1552261_at	18.931	A
1552263_at	324.449	P
1552264_a_at	373.9543	P
1552266_at	0.8755866	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885281">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient1 metastasis tumor cells</Title>
    <Accession database="GEO">GSM1885281</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient metastasis</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
metastatic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from metastatic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885281/suppl/GSM1885281_LGSOC-Patient01_metastasis_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	2055.087	P
1053_at	153.728	P
117_at	43.92621	P
121_at	3105.532	P
1255_g_at	3.214459	A
1294_at	425.8401	P
1316_at	169.4029	P
1320_at	64.22176	A
1405_i_at	22.21411	A
1431_at	36.54556	P
1438_at	9.280705	A
1487_at	580.5946	P
1494_f_at	71.61862	M
1552256_a_at	697.0048	P
1552257_a_at	1665.459	P
1552258_at	228.7053	P
1552261_at	28.31191	A
1552263_at	415.5273	P
1552264_a_at	438.8372	P
1552266_at	38.53714	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885282">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient2 primary tumor cells</Title>
    <Accession database="GEO">GSM1885282</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient primary tumor</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
primary
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from primary tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885282/suppl/GSM1885282_LGSOC-Patient02_primary_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	4671.138	P
1053_at	269.2867	P
117_at	159.2296	P
121_at	8565.2	P
1255_g_at	25.87063	A
1294_at	378.1266	P
1316_at	294.3344	P
1320_at	107.9014	A
1405_i_at	98.88361	P
1431_at	42.25019	P
1438_at	340.079	P
1487_at	563.5655	P
1494_f_at	85.81688	P
1552256_a_at	798.9548	P
1552257_a_at	374.9466	P
1552258_at	422.2133	P
1552261_at	461.5634	P
1552263_at	271.408	P
1552264_a_at	231.4136	P
1552266_at	22.77788	P
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885283">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient2 ascites tumor cells</Title>
    <Accession database="GEO">GSM1885283</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient ascites</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
ascitic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from ascitic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885283/suppl/GSM1885283_LGSOC-Patient02_ascites_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	2973.984	P
1053_at	528.9146	P
117_at	20.26227	A
121_at	13045.78	P
1255_g_at	2.783393	A
1294_at	363.5915	P
1316_at	190.745	P
1320_at	61.54673	P
1405_i_at	454.0505	P
1431_at	22.93997	P
1438_at	136.4969	P
1487_at	822.5403	P
1494_f_at	69.6596	A
1552256_a_at	2226.984	P
1552257_a_at	703.3998	P
1552258_at	238.47	P
1552261_at	83.01431	P
1552263_at	593.2069	P
1552264_a_at	464.0443	P
1552266_at	42.6503	M
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885284">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient2 metastasis tumor cells</Title>
    <Accession database="GEO">GSM1885284</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient metastasis</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
metastatic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from metastatic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885284/suppl/GSM1885284_LGSOC-Patient02_metastasis_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	3367.407	P
1053_at	482.4147	P
117_at	153.0556	P
121_at	11453.06	P
1255_g_at	4.215125	A
1294_at	289.411	P
1316_at	267.416	P
1320_at	102.3352	P
1405_i_at	35.28553	P
1431_at	24.76077	A
1438_at	276.1804	P
1487_at	552.5166	P
1494_f_at	81.00521	P
1552256_a_at	1433.328	P
1552257_a_at	302.5815	P
1552258_at	354.4962	P
1552261_at	639.891	P
1552263_at	355.5964	P
1552264_a_at	306.6156	P
1552266_at	39.47383	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885285">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient3 primary tumor cells</Title>
    <Accession database="GEO">GSM1885285</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient primary tumor</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
primary
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from primary tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885285/suppl/GSM1885285_LGSOC-Patient03_primary_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	9539.183	P
1053_at	465.8318	P
117_at	9.686475	A
121_at	10592.96	P
1255_g_at	30.48225	A
1294_at	687.0895	P
1316_at	125.9405	P
1320_at	97.23598	A
1405_i_at	79.42147	P
1431_at	130.4175	P
1438_at	39.27785	A
1487_at	1050.955	P
1494_f_at	85.73669	A
1552256_a_at	689.1614	P
1552257_a_at	3727.014	P
1552258_at	335.0849	P
1552261_at	79.32226	P
1552263_at	941.7526	P
1552264_a_at	586.8444	P
1552266_at	9.907511	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885286">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient3 ascites tumor cells</Title>
    <Accession database="GEO">GSM1885286</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient ascites</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
ascitic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from ascitic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885286/suppl/GSM1885286_LGSOC-Patient03_ascites_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	6039.365	P
1053_at	709.0414	P
117_at	8.569851	A
121_at	7525.226	P
1255_g_at	24.30098	A
1294_at	276.4693	P
1316_at	171.7331	P
1320_at	115.2435	A
1405_i_at	28.70669	A
1431_at	60.89509	P
1438_at	10.84104	A
1487_at	755.3025	P
1494_f_at	86.50407	A
1552256_a_at	617.7996	P
1552257_a_at	1860.711	P
1552258_at	185.0774	P
1552261_at	44.27952	A
1552263_at	722.1268	P
1552264_a_at	578.2345	P
1552266_at	35.7613	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM1885287">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2017-12-19</Last-Update-Date>
    </Status>
    <Title>LGSOC Patient3 metastasis tumor cells</Title>
    <Accession database="GEO">GSM1885287</Accession>
    <Type>RNA</Type>
    <Channel-Count>1</Channel-Count>
    <Channel position="1">
      <Source>LGSOC patient metastasis</Source>
      <Organism taxid="9606">Homo sapiens</Organism>
      <Characteristics tag="tumor type">
metastatic
      </Characteristics>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
Isolation of RNA was performed using the Trizol method (Invitrogen) and was purified using RNeasy spin columns (Qiagen) according to the manufacturers' protocols.
      </Extract-Protocol>
      <Label>biotin</Label>
      <Label-Protocol>
Label protocol was carried out according to the Eukaryotic Target Preparation protocol in the Affymetrix technical manual (701021 Rev. 5) for Genechip Expression analysis (Affymetrix).
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.
    </Hybridization-Protocol>
    <Scan-Protocol>
PICR scanner 3000
    </Scan-Protocol>
    <Description>
Gene expression data from metastatic tumor cells.
    </Description>
    <Data-Processing>
The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.
    </Data-Processing>
    <Platform-Ref ref="GPL570" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="CEL">
ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1885nnn/GSM1885287/suppl/GSM1885287_LGSOC-Patient03_metastasis_tumor_cells.CEL.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>MAS5.0 signal intensity</Description>
      </Column>
      <Column position="3">
        <Name>ABS_CALL</Name>
      </Column>
    <Internal-Data rows="20">
1007_s_at	2377.591	P
1053_at	557.7451	P
117_at	30.05015	P
121_at	438.6864	P
1255_g_at	11.91262	A
1294_at	482.2198	P
1316_at	232.695	P
1320_at	79.66136	A
1405_i_at	60.07373	M
1431_at	110.2078	P
1438_at	9.66572	A
1487_at	453.7224	P
1494_f_at	114.681	P
1552256_a_at	1719.496	P
1552257_a_at	1271.362	P
1552258_at	221.4504	P
1552261_at	35.68583	A
1552263_at	652.3339	P
1552264_a_at	524.8216	P
1552266_at	2.308193	A
    </Internal-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE73091">
    <Status database="GEO">
      <Submission-Date>2015-09-16</Submission-Date>
      <Release-Date>2017-12-19</Release-Date>
      <Last-Update-Date>2019-03-25</Last-Update-Date>
    </Status>
    <Title>Gene expression profile of tumor cells from primary tumors, ascites and metastases of low grade serous ovarian cancer patients</Title>
    <Accession database="GEO">GSE73091</Accession>
    <Pubmed-ID>30710055</Pubmed-ID>
    <Summary>
Differ from the aggressive nature of HGSOC (high grade serous ovarian cancer), LGSOC (low grade serous ovarian cancer) is characterized by an early age of disease onset, slow growth pattern, and poor response to chemotherapy. To understand more specifically the underlying gene profiling discrepancy that contributes to their behavior distinction, we performed parallel gene expression profiling in 9 magnetic sorted tumor cells samples from matched primary tumors, ascites and metastases of 3 LGSOC patients as in HGSOC. By comparing the expression data among primary tumor cells, ascitic tumor cells and metastasis tumor cells, we identified a set of differential expressed genes along LGSOC progression. Further study revealed that the gene phenotype perturbance along LGSOC progression was quite different from that of HGSOC patients.
We used microarrays to profile the expression of 9 matched tumor cells samples in order to identify molecular alteration between primary tumor cells, ascitic tumor cells and metastatic tumor cells in low grade serous ovarian cancer.
    </Summary>
    <Overall-Design>
Transcriptome profiling analyses were performed on 9 magnetical sorted epithelial tumor samples from matched primary tumors, ascites and metastases in low grade serous ovarian cancer patients, using the Affymetrix human genome U133 Plus 2.0 microarray.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib1" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM1885279" />
    <Sample-Ref ref="GSM1885280" />
    <Sample-Ref ref="GSM1885281" />
    <Sample-Ref ref="GSM1885282" />
    <Sample-Ref ref="GSM1885283" />
    <Sample-Ref ref="GSM1885284" />
    <Sample-Ref ref="GSM1885285" />
    <Sample-Ref ref="GSM1885286" />
    <Sample-Ref ref="GSM1885287" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE73nnn/GSE73091/suppl/GSE73091_RAW.tar
    </Supplementary-Data>
    <Relation type="SubSeries of" target="GSE73168" />
    <Relation type="BioProject" target="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA296123" />
  </Series>

</MINiML>
